| Identification | Back Directory | [Name]
Temazepam-d8 (exempt preparation) | [CAS]
2747917-64-0 | [Synonyms]
Temazepam-d8 (exempt preparation)
7-chloro-1,3-dihydro-3-hydroxy-1-(methyl-d3)-5-(phenyl-d5)-1,4-benzodiazepin-2-one | [Molecular Formula]
C16H5ClD8N2O2 | [MOL File]
2747917-64-0.mol | [Molecular Weight]
308.789 |
| Hazard Information | Back Directory | [Description]
Temazepam-d8 (exempt preparation) (Item No. 23789) is intended for use as an internal standard for the quantification of temazepam (Item No. ISO60182). Temazepam is categorized as a benzodiazepine.1 Temazepam has sedative-hypnotic properties and misuse via intra-arterial injection has been associated with tissue damage and subsequent amputation.2,3 Temazepam is regulated as a Schedule IV compound in the United States. Temazepam-d8 (exempt preparation) (Item No. 23789) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [Description]
Temazepam-d8 (Item No. 18481) is an analytical reference material intended for use as an internal standard for the quantification of temazepam (Item No. ISO60182). Temazepam is categorized as a benzodiazepine.1 Temazepam has sedative-hypnotic properties and misuse via intra-arterial injection has been associated with tissue damage and subsequent amputation.2,3 Temazepam-d8 is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. |
|
|